Avalo Therapeutics, Inc. (AVTX): SC 13G/A filed Nov 7, 2024

Form type

SC 13G/A

Filing date

Nov 7, 2024

Accession number

0001493152-24-044038

Filer

Avalo Therapeutics, Inc. (CIK 1534120)